Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
2 Different MYDX VIDEO'S: Saying stay tuned for MYDX Pen. 255 views so far.
I have received from irrefutable sources that MYDX is NOT paying for Dewald’s legal fees so that DREAM is DEBUNKED.
Still no revised MYDX 8k's - Possible MYDX merger/acquisition with CRYOPORT looking very positive.
In January of 2018, MyDx’s Biopharmaceutical division commenced clinical trials on its unique MyDx360 Pain Management Formula, appointed Dr. Heiner Dreismann, Former CEO of Roche Molecular Systems and Diagnostics Veteran to its Executive Advisory Board on April 24, 2018, secured city and state legal cannabis manufacturing and distribution for its MyDx360 customers in May 2018, and featured the Eco Smart Pen working Prototype on CFN Media in August 2018. The MyDx Analyzer was selected to be used in a large HIV Study by the University of Florida in September 2018. MyDx recruited Mr. Cannabis Group to operate the Company in November 2018, onboarding a new experienced CFO/CEO (Mr. Matthew Bucciero), a leading Harvard neuroscientist (Just Vincent) to its scientific advisory board, and Mr. Erai Beckmann, a seasoned cannabis industry professional, as a member of the Board.
MYDX:Involvement in Legal Proceedings
To the Company’s knowledge, none of our officers or our directors has, during the last ten years:
?
been convicted in a criminal proceeding or been subject to a pending criminal proceeding (excluding traffic violations and other minor offenses);
?
had any bankruptcy petition filed by or against the business or property of the person, or of any partnership, corporation or business association of which he was a general partner or executive officer, either at the time of the bankruptcy filing or within two years prior to that time;
?
been subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction or federal or state authority, permanently or temporarily enjoining, barring, suspending or otherwise limiting, his involvement in any type of business, securities, futures, commodities, investment, banking, savings and loan, or insurance activities, or to be associated with persons engaged in any such activity;
?
been found by a court of competent jurisdiction in a civil action or by the SEC or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated;
?
been the subject of, or a party to, any federal or state judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated (not including any settlement of a civil proceeding among private litigants), relating to an alleged violation of any federal or state securities or commodities law or regulation, any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order, or any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity;
PORTABLE DEVICE AND METHOD FOR VAPORIZING MATERIALS
Publication number: 20190014824
Abstract: A portable device, and more particularly a portable device for vaporizing materials such as oils for inhalation. Also, methods for vaporizing materials and methods of operating portable vaporizing devices. In addition, networks for providing operational features and/or instructions for operation of vaporizing devices and for monitoring and collecting operational data. In preferred embodiments, a vaporizing device and/or methods for operating a vaporizing device wherein the vaporizing device includes one or more of the following features: security features to regulate operation of the device; automatic detection of vaporizing material identity; user experience monitoring and data collection; and/or temperature adjustment of vaporizing material based on detected material for vaporization.
Type: Application
Filed: November 21, 2017
Publication date: January 17, 2019
Inventors: Daniel Yazbeck, Joshua Londano, James Panther, Jason Panther
https://patents.justia.com/inventor/daniel-yazbeck?fbclid=IwAR3UrUz5kPH_YRaYvRl7rF_rrk79Xuj1viP3-YG0c8h60_GAtkKg_KnEII4
IT'S COMING: MYDX Eco Smart Pen app picture: https://investorshub.advfn.com/uimage/uploads/2018/9/10/cssxwCOINS2.PNG
MYDX VIDEO, 8,751 views, 3 negative comments out of EIGHT THOUSAND SEVEN HUNDRED FIFTY ONE VIEWS. WOW, Just more proof that MYDX is COMING! https://mclip.tv/video/gTLqyHPtirU/mydx-review-by-slink-johnson-at-high-times-cannabis-cup
MYDX VIDEO: almost 34,495 views, but no body is watching, lol. https://mclip.tv/video/g6yj281aNig/mydx-portable-cannabis-tester
MYDX #4 on the Most Posted Cannabis Stocks Board, soon to hit number 1.
PER 10k dated 04/25/19 The Dewald/Sanzeri case "HAS NOT BEEN DISMISSED"
Lawsuit Against Jerome Dewald and Skip Sanzeri
As previously disclosed, in July 2017, the Company and its CEO (collectively, the “Plaintiffs”) filed a lawsuit against Jerome Dewald and Skip Sanzeri. On or about July 9, 2018, the Company settled with Mr. Dewald and has dismissed the matter with prejudice as to Mr. Dewald. On or about July 25, 2018, the Company settled with Mr. Sanzeri, which settlement calls for settlement payments of $1,000 per month over the course of five months, after which the Company will dismiss the matter as to Mr. Sanzeri and fully dispose of the lawsuit. As of April 23, 2019, all five $1,000 payments have been made to the Company and the matter has not yet been dismissed.
MYDX interview where Daniel says MYDX has a smart pen and mydx created a smart pen for Mr.Cannibas.
CFN Media Interviews MyDx Inc. (MYDX) at NCIA 2018 https://www.cannabisfn.com/cfnvideo/?id=lXSj78HA
MYDX at MEDMEN Headquarters. Quote 'MYDX it’s gonna be a great year'
https://www.instagram.com/p/BtMvBI8AbuB/
MYDX Eco Smart Pen and app picture: I guess this picture doesn't exist either. LMAO.
https://investorshub.advfn.com/uimage/uploads/2018/9/10/cssxwCOINS2.PNG
MYDX RECRUITS MR. CANNABIS GROUP TO OPERATE COMPANY,
https://www.globenewswire.com/news-release/2018/11/13/1650316/0/en/MYDX-RECRUITS-MR-CANNABIS-GROUP-TO-OPERATE-COMPANY.html
How's this picture http://sharc-research.org/2018/10/16/sharc-student-andrew-fiore-to-use-portable-marijuana-analyzer-in-pilot-study/ showing a STUDENT AT UNIVERSITY OF FLORIDA holding a CannaDx tester with the quote of
'We are excited to share that student Andrew Fiore will be pursuing the use of the CannaDx sensor in a limited pilot study to evaluate the interest of marijuana analyzers in research participants!
This project highlights SHARC’s leading research that works to answer pressing questions about marijuana use. We are excited to see to follow Andrew’s progress.
SAN DIEGO, CA, Sept. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - MyDx, Inc. (OTC: MYDX), a leader in science based cannabis health technologies, is proud to announce that the University of Florida will be using our flagship product, the CannaDx Analyzer, in the largest prospective study to date focused on the health effects of marijuana in people living with HIV.
“With this study, we are taking an additional step in solidifying our position as a leader in science based cannabis health technologies. The CannaDx Analyzer is expected to be used in a large pre-clinical long term cannabis study that will track patient data,” stated Daniel Yazbeck, CEO of MyDx. “The science of cannabis is still in its infancy. Studies like these, conducted by reputable institutions like the University of Florida, and supported by MyDx, are paving the way for the future of cannabis science in this country.”
We first entered communications with the University of Florida back in December of 2017. After reviewing the CannaDx Analyzer’s specifications, abilities, and corresponding software application, we are happy to announce that our platform was the one selected for the study.
This is intended to be a long-term study to be conducted over the course of up to 5 years that has the potential to produce valuable data which could contribute to the future possibilities of cannabis being used as a real medicine.
Marijuana and Potential Long-term Effects Study Goals
The overarching goals of this study are to obtain evidence regarding the influence of marijuana on major health outcomes and behavior in persons living with HIV in order to help guide clinical recommendations and identify risk factors for consequences. The research team is especially interested in the relationship of marijuana to novel aspects of cognitive function (e.g. motivation, intention, planning) and to systemic inflammation.
The study will enroll 480 total participants, including 360 marijuana users and 120 non-users. Participants will be asked to complete a baseline visit, with yearly follow-up visits for up to five years.
During a visit, participants will be asked to:
Give a small blood sample
Give a small urine sample
Complete a 45-minute survey about their marijuana, alcohol, and drug use, sexual activity, pain levels, and mood
Complete approximately 2 hours of thinking and memory tasks on paper and on an iPad
The study would like to ask the participants to analyze the marijuana product that they consume using the MyDx device. This will be done by allowing participants to take the device home with a study phone that has the app on it to do a one-time test of their marijuana product. They will also enter some information in the app associated with their marijuana use (e.g., ailments trying to relieve, side effects).
The findings will inform HIV treatment providers and patients who are considering marijuana to manage HIV-related symptoms or the HIV disease itself, and will identify patterns of marijuana use that are most strongly associated with the incidence of substance use disorders.
The application of the MyDx analyzer in this study further solidifies our positioning of the company for a future exit.
2 Different MYDX VIDEO'S: Saying stay tuned for MYDX Pen. 253 views so far.
The ECOSmartPen is the most innovative, smartest vape pen on the market today, and the vape market is the highest grossing segment of the cannabis industry – so you know there’s a lot of competition.
You may not be able to trust or verify what is in your vaporizer from everyone, but with MyDx, you are assured of exactly what is in your cannabis. Not only do we offer the CannaDx cannabis flower analyzer to give you exact chemical profiles of different cannabis strains, but we have the world’s largest database of user-driven information and chemical profiles of cannabis formulations.
In addition to the already impressive child safety lock and dosage tracking capabilities of our vape pen and accompanying application, MyDx is able to analyze multiple strains and formulations to know exactly what is in the ECOSmartPen-compatible oil cartridges, which allows you to know exactly what to expect.
Here are three flavors which will be available soon with the ECOSmartPen!
Game Time
Game Time is an orange crush flavor which provides an energy boost, whether you’re about to work out or want to perk up. It is formulated to give you smoother and more focused mental clarity and elevates your metabolic rate to assist with natural weight loss and fat burning.
Bounce Back
Bounce Back is a smooth blueberry flavor made to help restore your energy, allow for faster muscle repair, and reduce pain and soreness in your muscles. It was designed to reduce recovery time in between training or working out and to help you see improvements faster.
Off Day
Off Day is a mint flavor, formulated to help naturally relax your muscles, whether you are an athlete on a rest day between workout, a person with muscle pain and soreness, or simply wanting a minty relaxing afternoon.
This chemical formulation reduces inflammation and pain, specifically muscle inflammation and soreness.
As more testing is complete and more cannabis brands become aware of our revolutionary ECOSmartPen, more and more branded cartridges will become available across the world.
So, have you pre-ordered your ECOSmartPen yet?
There is a REASON that this video has so many views, close to 500(started at 3), in less than 3 weeks. MYDX, IT'S COMING and everyone knows it. I can tell by responses on investor forums. It's only a matter of timing when MYDX is ready to open the 'NEWS FLOOD GATES'. I got a feeling it's IMMINENT.
PER 10k dated 04/25/19 The Dewald/Sanzeri case "HAS NOT BEEN DISMISSED"
Lawsuit Against Jerome Dewald and Skip Sanzeri
As previously disclosed, in July 2017, the Company and its CEO (collectively, the “Plaintiffs”) filed a lawsuit against Jerome Dewald and Skip Sanzeri. On or about July 9, 2018, the Company settled with Mr. Dewald and has dismissed the matter with prejudice as to Mr. Dewald. On or about July 25, 2018, the Company settled with Mr. Sanzeri, which settlement calls for settlement payments of $1,000 per month over the course of five months, after which the Company will dismiss the matter as to Mr. Sanzeri and fully dispose of the lawsuit. As of April 23, 2019, all five $1,000 payments have been made to the Company and the matter has not yet been dismissed.
2 Different MYDX VIDEO'S: Saying stay tuned for MYDX Pen. 249 views so far.
THE FACTS: CLAIM against MYDX for NON-DELIVERY of PAID PRODUCT...
This is the exact lawsuit against MYDX that apparently a Francois Du Toit from South Africa is claiming to have filled. His direct statement on another site is 'I ordered several MyDx units for agency stock from MyDx. I guess it was FOTGOTTEN to mention claim is for MULTIPLE UNITS. I find it odd that the address given in the lawsuit filed with California Court for the Plaintiffs is CALIFORNIA, not South AFRICA. It's so convenient to forget to mention it's for MULTIPLE ANALYZERS.
Direct quote from Francois Du Toit: I will clarify. Ordered several analyser units end october 2018.
Buyer protection plan described below: The question to ask is why would someone not go back through PAYPAL, since that is how they are claiming the units were paid for, and get a refund since PAYPAL guarantees a refund if any problems, then to have to file a lawsuit against MYDX. Maybe they did try paypal refund and cannot get it because it is NOT warranted.
"Buyer protection ensures you get what you pay for. When something goes wrong with your eligible transactions, PayPal Buyer Protection has you covered. Get a full refund if an eligible order isn't significantly as described, or doesn't arrive at your doorstep."
This case is still ongoing and has not be decided to be factual by anyone.
Have you seen the latest 2 MYDX videos.
Saying stay tuned for MYDX Pen. 248 views so far.
Let's get the facts correct. MYDX(YAZBECK) filed a lawsuit against DR.JESS(PEATROSS) FIRST. Then DR.JESS after a month of MYDX's lawsuit being filed, filed a Cross-Complaint - over a MONTH later. If you research the lawsuit case it is UNDER 'YAZBECK vs PEATROSS'. Wonder why she waited a month to file a cross complaint against MYDX, instead of being the first to file a lawsuit?? I'm sure all is on the up and up, LOL.
11/02/2018
Case Title:
YAZBECK vs PEATROSS [IMAGED]
Case Status:
Pending
Case Category:
Civil - Unlimited
Location:
North County
Case Type:
Contract - Other
Judicial Officer:
Jacqueline M. Stern
Case Age:
211 days
Department:
N-27
https://walletinvestor.com/stock-forecast/mydx-stock-prediction
What is the MyDx stock price / share price today?
The MyDx stock price is 0.00150 USD today.
Will MyDx stock price grow / rise / go up?
Yes. The MYDX stock price can go up from 0.00150 USD to 0.0674 USD in one year.
Is it profitable to invest in MyDx stock?
Yes. The long-term earning potential is +4395.360% in one year.
Will MYDX stock price fall / drop?
No (see above)
According to our live Forecast System, MyDx, Inc stock is an awesome long-term (1-year) investment*. "MYDX" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. Q&A about "MYDX" projections.
At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like MyDx, Inc (MYDX). If you are looking for stocks with good return, MyDx, Inc can be a profitable investment option. MyDx, Inc quote is equal to 0.00150 USD at 2019-06-01. Based on our forecasts, a long-term increase is expected, the "MYDX" stock price prognosis for 2024-05-22 is 0.0273 USD. With a 5-year investment, the revenue is expected to be around +1723.1%. Your current $100 investment may be up to $1823.1 in 2024.
Still no revised MYDX 8k's - Possible MYDX merger/acquisition with CRYOPORT looking very positive.
MYDX:Involvement in Legal Proceedings
To the Company’s knowledge, none of our officers or our directors has, during the last ten years:
?
been convicted in a criminal proceeding or been subject to a pending criminal proceeding (excluding traffic violations and other minor offenses);
?
had any bankruptcy petition filed by or against the business or property of the person, or of any partnership, corporation or business association of which he was a general partner or executive officer, either at the time of the bankruptcy filing or within two years prior to that time;
?
been subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction or federal or state authority, permanently or temporarily enjoining, barring, suspending or otherwise limiting, his involvement in any type of business, securities, futures, commodities, investment, banking, savings and loan, or insurance activities, or to be associated with persons engaged in any such activity;
?
been found by a court of competent jurisdiction in a civil action or by the SEC or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated;
?
been the subject of, or a party to, any federal or state judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated (not including any settlement of a civil proceeding among private litigants), relating to an alleged violation of any federal or state securities or commodities law or regulation, any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order, or any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity;
In January of 2018, MyDx’s Biopharmaceutical division commenced clinical trials on its unique MyDx360 Pain Management Formula, appointed Dr. Heiner Dreismann, Former CEO of Roche Molecular Systems and Diagnostics Veteran to its Executive Advisory Board on April 24, 2018, secured city and state legal cannabis manufacturing and distribution for its MyDx360 customers in May 2018, and featured the Eco Smart Pen working Prototype on CFN Media in August 2018. The MyDx Analyzer was selected to be used in a large HIV Study by the University of Florida in September 2018. MyDx recruited Mr. Cannabis Group to operate the Company in November 2018, onboarding a new experienced CFO/CEO (Mr. Matthew Bucciero), a leading Harvard neuroscientist (Just Vincent) to its scientific advisory board, and Mr. Erai Beckmann, a seasoned cannabis industry professional, as a member of the Board.
PORTABLE DEVICE AND METHOD FOR VAPORIZING MATERIALS
Publication number: 20190014824
Abstract: A portable device, and more particularly a portable device for vaporizing materials such as oils for inhalation. Also, methods for vaporizing materials and methods of operating portable vaporizing devices. In addition, networks for providing operational features and/or instructions for operation of vaporizing devices and for monitoring and collecting operational data. In preferred embodiments, a vaporizing device and/or methods for operating a vaporizing device wherein the vaporizing device includes one or more of the following features: security features to regulate operation of the device; automatic detection of vaporizing material identity; user experience monitoring and data collection; and/or temperature adjustment of vaporizing material based on detected material for vaporization.
Type: Application
Filed: November 21, 2017
Publication date: January 17, 2019
Inventors: Daniel Yazbeck, Joshua Londano, James Panther, Jason Panther
https://patents.justia.com/inventor/daniel-yazbeck?fbclid=IwAR3UrUz5kPH_YRaYvRl7rF_rrk79Xuj1viP3-YG0c8h60_GAtkKg_KnEII4
MYDX VIDEO, 8,751 views, 3 negative comments out of EIGHT THOUSAND SEVEN HUNDRED FIFTY ONE VIEWS. WOW, Just more proof that MYDX is COMING! https://mclip.tv/video/gTLqyHPtirU/mydx-review-by-slink-johnson-at-high-times-cannabis-cup
MYDX VIDEO: almost 34,495 views, but no body is watching, lol. https://mclip.tv/video/g6yj281aNig/mydx-portable-cannabis-tester
MYDX #4 on the Most Posted Cannabis Stocks Board, soon to hit number 1.
PER 10k dated 04/25/19 The Dewald/Sanzeri case "HAS NOT BEEN DISMISSED"
Lawsuit Against Jerome Dewald and Skip Sanzeri
As previously disclosed, in July 2017, the Company and its CEO (collectively, the “Plaintiffs”) filed a lawsuit against Jerome Dewald and Skip Sanzeri. On or about July 9, 2018, the Company settled with Mr. Dewald and has dismissed the matter with prejudice as to Mr. Dewald. On or about July 25, 2018, the Company settled with Mr. Sanzeri, which settlement calls for settlement payments of $1,000 per month over the course of five months, after which the Company will dismiss the matter as to Mr. Sanzeri and fully dispose of the lawsuit. As of April 23, 2019, all five $1,000 payments have been made to the Company and the matter has not yet been dismissed.
MYDX interview where Daniel says MYDX has a smart pen and mydx created a smart pen for Mr.Cannibas.
CFN Media Interviews MyDx Inc. (MYDX) at NCIA 2018 https://www.cannabisfn.com/cfnvideo/?id=lXSj78HA
MYDX at MEDMEN Headquarters. Quote 'MYDX it’s gonna be a great year'
https://www.instagram.com/p/BtMvBI8AbuB/
MYDX Eco Smart Pen and app picture: I guess this picture doesn't exist either. LMAO.
https://investorshub.advfn.com/uimage/uploads/2018/9/10/cssxwCOINS2.PNG
MYDX RECRUITS MR. CANNABIS GROUP TO OPERATE COMPANY,
https://www.globenewswire.com/news-release/2018/11/13/1650316/0/en/MYDX-RECRUITS-MR-CANNABIS-GROUP-TO-OPERATE-COMPANY.html
How's this picture http://sharc-research.org/2018/10/16/sharc-student-andrew-fiore-to-use-portable-marijuana-analyzer-in-pilot-study/ showing a STUDENT AT UNIVERSITY OF FLORIDA holding a CannaDx tester with the quote of
'We are excited to share that student Andrew Fiore will be pursuing the use of the CannaDx sensor in a limited pilot study to evaluate the interest of marijuana analyzers in research participants!
This project highlights SHARC’s leading research that works to answer pressing questions about marijuana use. We are excited to see to follow Andrew’s progress.
SAN DIEGO, CA, Sept. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - MyDx, Inc. (OTC: MYDX), a leader in science based cannabis health technologies, is proud to announce that the University of Florida will be using our flagship product, the CannaDx Analyzer, in the largest prospective study to date focused on the health effects of marijuana in people living with HIV.
“With this study, we are taking an additional step in solidifying our position as a leader in science based cannabis health technologies. The CannaDx Analyzer is expected to be used in a large pre-clinical long term cannabis study that will track patient data,” stated Daniel Yazbeck, CEO of MyDx. “The science of cannabis is still in its infancy. Studies like these, conducted by reputable institutions like the University of Florida, and supported by MyDx, are paving the way for the future of cannabis science in this country.”
We first entered communications with the University of Florida back in December of 2017. After reviewing the CannaDx Analyzer’s specifications, abilities, and corresponding software application, we are happy to announce that our platform was the one selected for the study.
This is intended to be a long-term study to be conducted over the course of up to 5 years that has the potential to produce valuable data which could contribute to the future possibilities of cannabis being used as a real medicine.
Marijuana and Potential Long-term Effects Study Goals
The overarching goals of this study are to obtain evidence regarding the influence of marijuana on major health outcomes and behavior in persons living with HIV in order to help guide clinical recommendations and identify risk factors for consequences. The research team is especially interested in the relationship of marijuana to novel aspects of cognitive function (e.g. motivation, intention, planning) and to systemic inflammation.
The study will enroll 480 total participants, including 360 marijuana users and 120 non-users. Participants will be asked to complete a baseline visit, with yearly follow-up visits for up to five years.
During a visit, participants will be asked to:
Give a small blood sample
Give a small urine sample
Complete a 45-minute survey about their marijuana, alcohol, and drug use, sexual activity, pain levels, and mood
Complete approximately 2 hours of thinking and memory tasks on paper and on an iPad
The study would like to ask the participants to analyze the marijuana product that they consume using the MyDx device. This will be done by allowing participants to take the device home with a study phone that has the app on it to do a one-time test of their marijuana product. They will also enter some information in the app associated with their marijuana use (e.g., ailments trying to relieve, side effects).
The findings will inform HIV treatment providers and patients who are considering marijuana to manage HIV-related symptoms or the HIV disease itself, and will identify patterns of marijuana use that are most strongly associated with the incidence of substance use disorders.
The application of the MyDx analyzer in this study further solidifies our positioning of the company for a future exit.
MYDX shareholder/investors I know DON'T CARE when 10Q comes out.
2 Different MYDX VIDEO'S: Saying stay tuned for MYDX Pen. 247 views so far.